— Know what they know.
Not Investment Advice

RCAR OTC

RenovaCare, Inc.
1W: +9900.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.8% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $8735 mcap · 22M float · 0.013% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.001
Volume3,335
Avg Volume2,923
Beta5.62
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHarmel Singh Rayat
Employees1
SectorHealthcare
IndustryBiotechnology
IPO Date1996-05-30
9375 East Shea Blvd
Scottsdale, AZ 85260
US
888 398 0202
About RenovaCare, Inc.

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Kirkland Kenneth A-Award 50,000 $1.91 2016-03-16
Rosen Rhonda Beth A-Award 20,000 $1.91 2016-03-16
SIERCHIO JOSEPH A-Award 50,000 $1.91 2016-03-16
RAYAT HARMEL S P-Purchase 2,173,913 $0.46 2016-02-02
RAYAT HARMEL S C-Conversion 2,173,913 $0.46 2016-02-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms